Hero Image

The 2nd International Electronic Conference on Biomedicines

01 - 31 March 2023 (CET)
Online
Event Announcement

ECB 2023 has been a success! Welcome to the new electronic conference, ECB 2025

Submit your abstract by 19th January 2025 Here

Register for free by 16th March 2025 Here


Welcome from
the chairs

Dear Colleagues,

It is our pleasure to invite you to join the 2nd International e-Conference on Biomedicines in 2023 (ECB 2023) that is hosted online by: https://ecb2023.sciforum.net.

ECB 2023 will present the latest research related to all aspects of research on human health and diseases, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. Topics of interest include, but are not limited to:

1. Frontiers of biomedicine in SARS-CoV-2
2. RNA Processing and Human Diseases
3. Extracellular Vesicles for Biomarker Discovery
4. Biomedicine in Cardiovascular Diseases
5. Medicinally Active Plants and Phytochemicals
6. Molecular Mechanisms of Neurodegeneration
7. Immune System, Tumor Immunology and Autoimmune Disease
8. Gut Microbiota and Biomedicine
9. Obesity and Metabolic Diseases
10. Nutraceuticals as Adjuvant Therapeutics
11. Organ-on-chip and Precision Medicine
12. Mitochondrial Diseases
13. Gastrointestinal Cancer
14. Regulation of Protein Synthesis in Health and Disease
15. Musculoskeletal Tissue Regeneration
16. Wound Healing
17. Peptide-Based Piezoelectric Materials
18. Viral Hepatitis and Transition
19. Chronic and Acute Kidney Injury – Prevention and Treatment
20. Nanomedicine, Combination Cancer Therapy and Immunotherapy

ECB 2023 seeks to fulfill the need of academics to gather together to share results and ideas by offering a completely digital (online) method of running this scientific conference. ECB 2023 will allow its participants to share their latest research results and receive instant feedback from their peers throughout the world through online forums. ECB 2023 will serve as a platform for advancing research in biomedicines. The greatest part is that there is no cost to participate in ECB 2023!

All submitted abstracts will be evaluated by the conference peer review committee. Upon acceptance, authors will contribute an extended abstract for the conference proceedings and a slide presentation of their work. The authors with outstanding contributions will be invited to submit full manuscripts for potential publication in the Biomedicines journal (https://www.mdpi.com/journal/biomedicines).

We hope you will choose to be a part of this exciting conference and present your most transformative research on biomedicines.

Prof. Dr. Jun Lu
Auckland University of Technology, New Zealand

Dr. Allan Stensballe
Aalborg University, Denmark

Follow the conference organizer on Social Media



Meet the Event Chairs

Prof. Dr. Jun Lu
Prof. Dr. Jun Lu
University of Auckland, Auckland, New Zealand
Dr. Allan Stensballe
Dr. Allan Stensballe
Aalborg University, Aalborg, Denmark

Important Dates


  • Abstract submission deadlineJan 05, 2023
  • Abstract acceptance notificationJan 16, 2023
  • Full file submission deadlineFeb 06, 2023

Meet Our Speakers

View all speakers
Dr. Stefano Bacci

Dr. Stefano Bacci

Research unit of Histology and Embriology, Department of Biology, University of Florence, Italy;
Dr. Stefano Bacci is a Professor of Cytology and Histology at the University of Florence and has resided, during his training, at the Schepens Eye Research Institute, Harvard Medical School, Boston (MA), USA. His main research concerns the understanding of the cellular mechanisms involved during wound healing in relation to different type of treatments. This research field has also led him to resolve important questions on the vitality of the lesion by proposing methods that are considered important in the forensic field. He is the author of more than 100 articles within his research sector, including publications of high scientific impact. For other related information, please see the following web page: https://sciprofiles.com/profile/915428.

Dr. Gianluigi Mazzoccoli

Dr. Gianluigi Mazzoccoli

Department of Medical Sciences, Division of Internal Medicine and Chronobiology Laboratory, Fondazione IRCCS Casa Sollievo della Sofferenza, Italy;
Since 2022, Contract Professor for teaching of the Chronobiology Course as part of the Elective Didactic Activity at the Department of Medical and Surgical Sciences, Master's Degree Course in Medicine and Surgery of the University of Foggia, Foggia, Italy Since 2022 National Scientific Habilitation (Ministry of Education – Italy, Bando D.D. 553/2021 competitive sector 05/F1 Applied Biology (BIO/13) - Full Professor Since 2019 National Scientific Habilitation (Ministry of Education – Italy, Bando D.D. 1532/2016) competitive sector 05/E2 Molecolar Biology (BIO/11) - Associate Professor Since 2018 Visiting Scientist and Doctorate in Medicine, Pathology and Gerontology (Honoris Causa) at the Saint Petersburg Institute of Bioregulation and Gerontology, Saint Petersburg, Russia 2014-2017 Visiting Scientist at the University College London, lnstitute for Liver and Digestive Health, Division of Medicine, The Royal Free Hospital, London, United Kingdom 2011-2013 Visiting Scientist at the Institute of Hepatology, Foundation for Liver Research and Birkbeck College, University of London, London, United Kingdom. Since 2011 Senior Scientist of the Chronobiology Laboratory at the IRCCS Scientific Institute and Regional General Hospital “Casa Sollievo della Sofferenza” San Giovanni Rotondo (FG), Italy. 2003-2005 Contract Professor of Medical Oncology at the School for Obstetrics at the University of Foggia, Foggia, Italy. Since 1993 Visiting Scientist at the Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy Since 1991 attending Physician and Researcher at the Department of Medical Sciences, Division of Internal Medicine, IRCCS Scientific Institute and Regional General Hospital “Casa Sollievo della Sofferenza” San Giovanni Rotondo (FG) Italy. 1987-2012 collaboration with the Chronobiology Laboratories, University of Minnesota, Minneapolis, USA .Board of Internal Medicine, University of Florence, Italy, in 1993. Medical School Diploma, University of Florence, Italy, in 1987 (summa cum laude)

Dr. Noemi Rotllan Vila

Dr. Noemi Rotllan Vila

IIB SANT PAU, CIBERDEM, Barcelona, Spain;
Noemi Rotllan obtained her B.Sc and MS in Biology in 1996 from the University of Barcelona. She also earned her Ph.D. degree in 2008. She did her 1st postdoctoral trainee in Dr. Edward Fisher laboratory at NYU with a Fulbright fellowship. Following that, she did a 2nd postdoctoral trainee in Dr. Carlos Fernández Hernando laboratory at NYU and Yale University, where she was an Associate Research Scientist. Dr.Rotllan was also a recipient of the Scientific Development Grant award from the AHA. In 2019 she moved back to Barcelona where she starts her own laboratory with the prestigious Ramon y Cajal fellowship award. Her research interests are focused mainly on the role of new microRNAs in regulating lipoprotein metabolism and the progression of atherosclerosis and to use an innovative therapeutic approach for targeting miRNAs in vivo.

Dr. Sonia Benítez González

Dr. Sonia Benítez González

Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau), Spain;
Dr. Sonia Benitez. Bachelor in Biochemistry (1996) and PhD in Biochemistry (2002) by Autonomous University from Barcelona. From 1996 in the Cardiovascular Biochemistry Group, Institut Investigació Biomèdica Sant Pau (IIB Sant Pau); Hospital de la Santa Creu i Sant Pau, Barcelona. Senior Investigator Website: http://www.recercasantpau.cat/grup/bioquimica-cardiovascular.

Dr. Krisztina NIKOVICS

Dr. Krisztina NIKOVICS

Imagery Unit, Department of Platforms and Technology Research, French Armed Forces Biomedical Research Institute, France;
French Armed Forces Biomedical Research Institute, IRBA 1, place Général Valérie André BP 73 ; 91223 Brétigny sur Orge, France Field of interest: in particular the characterization of in situ macrophages and the analysis of the communication between different cells in the context of tissue regeneration, with special emphasis on the study of cytokine-cytokine receptor interactions in situ.

Dr. Zoran Minic

Dr. Zoran Minic

Department of Chemistry and Biomolecular Sciences, John L. Holmes Mass Spectrometry Facility, Faculty of Science, University of Ottawa, Canada;
Zoran Minic received his Ph.D. degree in Plant Biology and Biochemistry at the Université de Paris 11, France, in 1998 and his Habilitation (HDR) in science at the Université de Paris 7, in 2004. He worked as a research associate at the Université de Pierre et Marie Curie (Paris, France) and at the Institut National de la Recherche Agronomique (Versailles and Jouy en Josas, France). After relocating to Canada in 2007, he initially worked as a professional research associate at the University of Saskatchewan. Since 2013, at the University of Regina, he worked as a facility manager responsible for the high-throughput proteomics platform in the Proteomics and Genomics core facility. Since 2017, he has been working as a core facility manager of biological John L. Holmes Mass Spectrometry Facility at the University of Ottawa. He is responsible for the development of large-scale proteomics and metabolomics analysis methodologies using state-of-the-art mass spectrometers. During his research and managerial career, he acquired a strong background in proteomics, metabolomics, system biology, liquid chromatography, and mass spectrometry. He is involving in many collaborative projects with industry and academia. His personal research project is related to using omics approaches to study extracellular vesicles for diagnosis and treatment of cancer. He is the author/co-author of more than 70 academic journal articles, books chapters and patents.

Dr. Giuseppina Catanzaro

Dr. Giuseppina Catanzaro

Department of Experimental Medicine, Sapienza University of Rome, Italy;
Dr. Giuseppina Catanzaro is a Research Assistant in the Department of Experimental Medicine in Sapienza University of Rome. She received her PhD in Biotechnology from the University of Teramo and pursued her post-doctoral studies in the field of Biochemistry in the laboratory of Prof. Maccarrone. She joined a post-doc in the Bracco Research Center where she was in charge of the biological part of a vast multidisciplinary research project involving cancer cell metabolism, collaborating with the Albeda Research Group in Copenhagen (Denmark) to study the metabolic activity of several cancer cells. Then, she moved in Sapienza University where she has been involved in several projects focused on the molecular and clinical aspects of cancers. Her activity is especially concentrates on defining the role of non-coding RNAs as key molecules in cancer and metabolic diseases, both for their biological functions and for their role as diagnostic, prognostic and predictive biomarkers. She is author of more than 40 original peer-reviewed papers and in the last years she contributed to increase the knowledge about the role of microRNAs, with a special focus on pediatric neuro-oncology. For her research, she won many prestigious awards, such as the Ricerche Oncologiche di Base award in 2018 and in 2022, and a special Mention for the best video for EXPO 2020 Dubai for the call “Beyond borders: La conoscenza unisce le persone” sponsored by Fondazione Bracco.

Dr. Montserrat Fernández-Guarino

Dr. Montserrat Fernández-Guarino

Servicio de Dermatología, Head of Hospitalization and Emergencies in Dermatology, Hospital Ramon y Cajal Madrid, Spain;
Prof Montserrat Fernández-Guarino is a Specialist in Dermatology since 2008. Trained in Ramón y Cajal Dermatology Service, she obtained the Doctoral Thesis with Cum Laude and was selected as the ""Extraordinary Thesis award"" as the best thesis of the year in Alcala University. Dra Fernández-Guarino is certified in Psychology and has four different Master degrees focused on health assistance as nutrition, pharmacy, rehabilitation and hospital management. Dra Fernández-Guarino is accredited by the National Spanish Education Ministry as a Professor of Medical University (ANECA). She has developed as a Principal investigator and as a collaborator, different investigation research in partnership with industry and in competitive calls in private and public calls. Summary of the present position: -Staff Dermatologist at Hospital Universitario Ramón y Cajal, Madrid (2008-present) -Tutor of Dermatologist residents and residents of other medical specialist (Internal Medicine, Immunology, Allergy). -Coordinator of Emergencies in Dermatology of the Hospital. -Head of the Hospitalization in Dermatology. -Consultant of investigation in Photodynamic therapy. - Part-time private practice in General, Dermatology in my own Clinic (Madriderma) Main interests General dermatology, clinical dermatology, photobiology, phototherapy, photodynamic therapy, lasers, complex dermatology, inflammatory dermatology, emergencies in dermatology, photodynamic therapy, wound healing

Dr. Frédéric Velard

Dr. Frédéric Velard

Université de Reims Champagne-Ardenne, EA 4691 BIOS, 51 Rue Cognacq Jay, France;
Frédéric VELARD, PhD-HDR, Research Engineer in the BIOS laboratory from University of Reims Champagne-Ardenne. Forty years old, he defended his PhD thesis in 2009 (INSERM UMRS-926, Reims). His work focused on acute inflammation control through the effect of zinc-doped ceramics. Especially, he has worked on PMNs response to HAp particles and the importance of IL-8 chemokine production in aseptic loosening of orthopedic implants. During post-doctoral fellowship in INSERM UMRS-606, Paris, he has worked on arthritis and osteoarthritis development due to chondrocytes apoptosis both in inflammatory and hypoxic environment. He joined his current laboratory in 2011 (getting his tenure position in 2014), to develop programs in close relation with the understanding of inflammatory processes in bone tissue regeneration and physiology. Author of 53 indexed publications he presented his works in more than 100 national and international conferences. He supervised 8 PhD students (4 former, 4 co-supervised on-going). F. Velard coordinated several local and national institutional research programs as well as collaborative contracts with industrial partners. Nowadays, he works on programs aiming at tools development to enhance bone regeneration, ranging from i) bone substitute conceptualization through ii) deepen understanding of cells deficient maturation and communication in bone thanks to rare disease models, in order to find new ways to promote bone homeostasis for all patients who suffers from hard tissues alterations.

Prof. Dr. M. R. Mozafari

Prof. Dr. M. R. Mozafari

Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia;
Expert in Nano-biotechnology, Encapsulation & Targeting of Bioactive agents with substantial number of publications, 12 Patents, 5 Books & several Book-chapters. Author of the first book on Nanoliposomes; completed many industrial research projects, developed methods (e.g. “Mozafari Method”) for large-scale manufacture of controlled-release systems without using toxic agents. Recently introduced a novel technology for the encapsulation and delivery of bioactive material called "Tocosome".

Dr. Helene Boeuf

Dr. Helene Boeuf

Université de Bordeaux, Bordeaux, France;

Session Topics
Explore more details
  • S1. RNA Processing and Human Diseases
  • S2. Molecular Mechanisms of Neurodegeneration
  • S3. Extracellular Vesicles for Biomarker Discovery
  • S4. Medicinally Active Plants and Phytochemicals
  • S5. Wound Healing
12

Sponsors and Partners

Organizer


BiomedicinesMDPI

Media partner


Anesthesia ResearchBioengineeringDiagnosticsInternational Journal of Molecular SciencesMicroorganismsNeurology InternationalPharmaceuticalsPharmaceuticsViruses
ECB 2023 is closed. Thank you for your participation.
The recordings of ECB 2023 live sessions are available at: https://ecb2023.sciforum.net/#recordings
All participants of ECB 2023 are welcome to submit an extended full paper to the Special Issue "Selected Papers in the 2nd International Electronic Conference on Biomedicines (ECB 2023)" of the journal Biomedicines, with a 20% discount on the Article Processing Charges.
The ECB 2023 award winners have been announced at https://ecb2023.sciforum.net/#awards
Live Sessions Information
During the duration of the conference, a number of live online sessions will be programmed. The live-streaming platform we are using is Zoom. During each session, the participants will have the possibility to ask questions during a Q&A session. Detailed information about the topics and dates will be shared soon.

The live sessions are
free of charge. The authors who submit submissions to ECB 2023 will have priority for registration (with no extra cost) to the live online sessions with our keynote speakers. If it is not completely full, registration will be open for unregistered participants. Registrations with academic institutional email addresses will be prioritized. The number of participants in the live session is limited but the recording will be made available on Sciforum shortly afterward.

We are pleased to invite you to subscribe to our conference so that you can receive email notifications when the live session program is online and open online discussions.
Live Session Recordings

Live Session 1 - RNA Processing and Human Diseases



Live Session 2 - Musculoskeletal Tissue Regeneration

Live Session 3 - Biomedicine in Cardiovascular Diseases

Live Session 4

Live Session 5 - Wound Healing

Content Locked
You need to log in and have a confirmed registration to view this content.
Conference Secretariat

Ms. Maria Li
Ms. Suzie Song
Ms. Alethea Liu

MDPI Branch Office, Wuhan
E-Mail: ecb@mdpi.com

Sponsoring Opportunities
For information regarding sponsoring opportunities, please contact the conference secretariat.


Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility